Sophie Voruz - Publications

Secondary BRAF-mutated histiocytic/dendritic cell sarcoma transdifferentiated from follicular lymphoma with prolonged response to BRAF/MEK inhibition and subsequent evolution to high-grade B-cell lymphoma.

Journal: Journal of clinical pathology

Published: January 14, 2026

A Novel Heterozygous Mutation in FGB (c.1231_1232 del GA) Causing Hypofibrinogenemia With Mild Bleeding in a Large Swiss family.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 19, 2025

Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript.

Journal: Annals of hematology

Published: May 12, 2023

Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript.

Journal: Biomarker research

Published: October 08, 2021

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.

Journal: Experimental hematology & oncology

Published: March 08, 2021

Combined Lung and Liver Transplantation for Short Telomere Syndrome.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: November 29, 2019

Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.

Journal: Blood transfusion = Trasfusione del sangue

Published: October 09, 2019

Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.

Journal: British journal of haematology

Published: August 16, 2018

Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".

Journal: Haematologica

Published: March 02, 2018

Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.

Journal: Haematologica

Published: November 04, 2017